Here are relevant reports on : regenerative-medicine-market
-
Sustainable Agriculture Market by Type (Organic Farming, Agroecology, Regenerative Agriculture, Conservation Agriculture, and Precision Agriculture), Application (Food Production, Bioenergy, Environmental Services, and Water Management), and Region - Global Forecast to 2029
The global market for sustainable agriculture, estimated to be US$ XX.X billion by 2024, has an impressive growth forecast, with growth expected to reach $XXX.X billion by 2029 at a compound annual growth rate (CAGR) of 6.1%. that is, within the forecast period. The key players in this market include Organic Valley (US), Nature's Path Foods (US), Eden Foods, Inc. (US), Deere & Company (US), Trimble Inc. (US), AGCO Corporation (US), AgJunction LLC (US), Raven Industries, Inc. (US), AG Leader Technology (US), Teejet Technologies (US), Topcon (US), Taranis (Israel), and others
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Regenerative Agriculture Market by Practice (Aquaculture, Agroecology, Agroforestry, Biochar & Terra Preta, Holistically Managed Grazing, No-Till & Pasture Cropping, Silvopasture), Application and Region - Global Forecast to 2027
The regenerative agriculture market is experiencing an exceptional period of growth, with a projected increase from US$ 8.7 billion in 2022 to an incredible US$ 16.8 billion by 2027. Key players in this market include Nestle SA (Switzerland), Danone SA (France), General Mills, Inc (US), Cargill Incorporated (US), Unilever PLC (United Kingdom), Grounded (South Africa), Soil Capital Belgium SPRL (Belgium), Indigo Ag, Inc (US), and Serenity Kids (US).
- Published: December 2022
- Price: $ 4950
- TOC Available:
-
Cryocooler Market by Recuperative Heat Exchanger, Regenerative Heat Exchanger, Heat Dissipation Pipe, Preventive Maintenance Services, Gifford-McMahon Cryocoolers, Stirling Cryocoolers, Joule Thomson Cryocoolers, Military, Space - Global Forecast to 2030
The cryocooler market is expected to grow from USD 3.48 billion in 2025 to USD 4.90 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% during the forecast period. The Key Players Sumitomo Heavy Industries, Ltd. (Japan), Thales (France), AMETEK.Inc. (US), Edwards Vacuum (UK), Chart Industries, Inc. (US), Air Liquide Advanced Technologies (France), ULVAC CRYOGENICS INC. (Japan), RICOR (Israel), Bluefors (Finland), and Northrop Grumman (US).
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Automotive Ultra-Capacitor Market by Power Modules (volts), Application (Start-Stop Application, Regenerative Braking System, Active Suspension), Components, by Transport mode, Electric Vehicle, by Region - Global Forecast to 2025
Ultra-capacitors are electrical energy storage devices. Ultra-capacitors are used in buses, trucks, trains, and other vehicles. The electric vehicle is one of the major areas where the application of ultra-capacitors is expected to grow at a rapid pace. Government subsidies and incentives have provided the manufacturers the required impetus to promote electric vehicles. Ultra-Capacitors in electric vehicles have a high potential in the automotive industry; however, their development requires continuous collaboration between vehicle manufacturers and battery manufacturers.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Electroceuticals Market / Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation (Deep Brain Stimulation)), Type (Implantable, Non-Invasive), Application (Arrhythmia, Heart Failure, Epilepsy) & Region - Global Forecast to 2029
The global electroceuticals market, valued at US$21.9 billion in 2023, stood at US$23.9 billion in 2024 and is projected to advance at a resilient CAGR of 7.0% from 2024 to 2029, culminating in a forecasted valuation of US$33.6 billion by the end of the period. Growth of the overall market is largely driven by the increasing incidence of cardiovascular, hearing loss and neurological disorders, increasing research in these field of disorders, and rising awareness regarding electroceuticals devices.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Europe Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, RPM, Immunotherapy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The Europe artificial intelligence (AI) in healthcare market is projected to reach USD 31.72 billion by 2030 from USD 6.12 billion in 2025, at a CAGR of 39.0% during the forecast period. The prominent players operating in the Europe artificial intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), and Amazon Web Services, Inc. (US), among others. These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the Europe artificial intelligence (AI) in healthcare market.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Molecular Cytogenetics Market by Product (Kits, Reagents, Probes, Instrument, Software, Services), Technique (FISH, CISH, Comparative Genomic Hybridization [Array-based, Standard]), Application (Cancer, Personalized Medicine) - Global Forecast to 2030
The global molecular cytogenetics market, valued at US$0.97 billion in 2024, stood at US$1.02 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2030, culminating in a forecasted valuation of US$1.43 billion by the end of the period. The market growth is fueled by increasing incidence of cancer & genetic disorders and rising usage of molecular cytogenetics in clinical pathology testing.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP), & End User -Global Forecast to 2030
The global AI in Precision Medicine market, valued at US$0.60 billion in 2023, stood at US$0.78 billion in 2024 and is projected to advance at a resilient CAGR of 30.7% from 2024 to 2030, culminating in a forecasted valuation of US$3.92 billion by the end of the period. Growth in precision medicine, AI’s efficiency in drug discovery, integration of Real-World Evidence (RWE) in emerging markets to drive the market significantly.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Nuclear Medicine Software Market by Software (Image Management, Workflow, PACS, Dosimetry, Treatment, AI/Analytics), Application (Diagnosis, Treatment, Theranostics, Research), Disease (Onco, Neuro, Cardio), End User & Region - Global Forecast to 2030
The global nuclear medicine software market, valued at US$887.5million in 2024, stood at US$970.0 million in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of US$1,491.5 million by the end of the period. This growth is mainly driven by the increasing demand for early and accurate diagnostics, as precision imaging is essential for treatment planning.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
